GuidelineActa dermato-venereologica2025
European S2k Guideline on Chronic Pruritus
Guideline in Acta dermato-venereologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Broadening the View: Substance P and Its Metabolism in Pruritus-Related Diseases.The Journal of dermatology · 2026Review
- [When itch does not stop : Case report on the diagnostic responsibility of dermatology].Dermatologie (Heidelberg, Germany) · 2026Article
- [How classification and guidelines simplify the care of pruritus patients. A guest commentary].Dermatologie (Heidelberg, Germany) · 2026Article
- [When the etiology remains unclear: status quo of chronic pruritus of unknown origin].Dermatologie (Heidelberg, Germany) · 2026Article
- [Chronic prurigo: overview of pathophysiology, diagnosis, and treatment].Dermatologie (Heidelberg, Germany) · 2026Review
- [Pruritus and stress: psychoneuroimmunological mechanisms, assessment of psychosocial stress, and therapeutic implications].Dermatologie (Heidelberg, Germany) · 2026Review
- Catastrophizing in Chronic Itch: Associations with Demographic, Clinical and Psychological Factors.Acta dermato-venereologica · 2026Article
- Modern wITCHcraft: Conjuring pruritus-associated gene signatures through microarray profiling.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Article
- Uremic Pruritus in Hemodialysis: Mechanisms, Burden, and Emerging Therapies.Journal of clinical medicine · 2026Review
- Breaking the vicious cycle: a bibliometric and visual analysis of the bidirectional relationship between pruritus and negative emotions.Frontiers in psychiatry · 2026Review
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study.Clinical, cosmetic and investigational dermatology · 2026Article
- Pruritus in Europe's Aging Populations: Regional and National Patterns, 1990-2023, and Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023.Clinical, cosmetic and investigational dermatology · 2026Article
- IgE-defined endotypes reveal distinct clinical profiles of prurigo nodularis compared with atopic dermatitis: a multicenter study in China.Frontiers in allergy · 2026Article
- Article
- [The new and updated European S2k guideline on chronic pruritus 2025: a comment].Dermatologie (Heidelberg, Germany) · 2025Review
- Global, regional, and national burdens of pruritus in children and adolescents aged under 20 years from 1990 to 2021: a trend analysis.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pruritus is a frequent symptom in medicine. Population-based studies show that one in five persons in the general population has suffered from chronic pruritus (CP) at least once in their lifetime, with a 12-month incidence of 7%. CP, which can affect all age groups, is associated with numerous, often interdisciplinary medical conditions. It needs a precise diagnostic work-up to identify causes and relevant comorbidities. Management of CP comprises treatment of the underlying disease as well as topical and systemic therapies. Treating CP needs to be targeted, multimodal and performed in a step-wise procedure requiring an interdisciplinary approach. In recent years, novel on-label therapies have been approved for CP, including therapies for chronic prurigo and cholestatic pruritus. We present the updated European guideline on chronic pruritus by a team of European pruritus experts from different disciplines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.